Recent Finacing
Recent Raise
Corsair Pharma is a biopharmaceutical company developing a once-daily transdermal prodrug patch that delivers skin-permeable treprostinil prodrugs converted in the liver to provide continuous PAH therapy, in clinical development.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
